Search results
Found 8 matches for
The 5-year programme award will support research on the DNA repair mechanisms that protect cancer cells from therapy, informing the development of future treatments.
Angela Vincent honoured for excellence in epilepsy research
NDCN
17 December 2019
Emeritus Professor Angela Vincent received the Research Recognition Award, clinical science, at the annual meeting of the American Epilepsy Society.
New research to investigate role of blood-brain barrier
NDCN
12 February 2019
A new consortium of 27 partners coordinated by our researcher Prof Zameel Cader will tackle the challenge of discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics.
European licence for migraine prevention drug
NDCN
31 July 2018
MRC WIMM research underpins the first treatment designed specifically for the prevention of migraines
World’s largest autism grant will transform research landscape
NDCN
18 June 2018
The largest research grant ever given for neurodevelopmental conditions has been awarded by the Innovative Medicines Initiative to an international consortium that includes the participation of Prof Zameel Cader.
Oxford Centre for Neuroinflammation launched
MRC HIU NDCN
30 May 2018
The new centre, located at the MRC WIMM, aims to shed light on the causes of neurodegenerative diseases and uncover new treatment pathways.
Prof David Beeson elected Fellow of the Academy of Medical Sciences
NDCN
10 May 2018
Many congratulations to Prof Beeson for this distinction recognising his exceptional contribution to the study of neuromuscular disorders.
MRC WIMM researchers talk about their research on rare diseases
Department of Oncology MRC MHU NDCN RDM
28 February 2018
To mark rare disease day we asked our researchers to tell us more about the rare conditions that they study, and why their research is important.